Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Anna Lechanteur"'
Autor:
Isaie Nyamba, Alexis M W Nembot, Bavouma Charles Sombié, Hermine Zimé-Diawara, B. G. Josias Yaméogo, Anna Lechanteur, Christian Damblon, Rasmané Semdé, Brigitte Evrard
Publikováno v:
Journal Africain de Technologie Pharmaceutique et Biopharmacie, Vol 3, Iss 1 (2024)
Solid dispersion formation by Hot melt extrusion (HME) is a widely used formulation strategy to improve the solubility and bioavailability of poorly water-soluble drugs. Despite this, they are limited by various factors such as drug-excipient miscibi
Externí odkaz:
https://doaj.org/article/c69a06331fdf4de0a44cfedd4b1891a8
Autor:
Isaïe Nyamba, Alexis M W Nembot, Charles B Sombié, Hermine Zimé Diawara, Josias B.G. Yaméogo, Anna Lechanteur
Publikováno v:
Journal Africain de Technologie Pharmaceutique et Biopharmacie, Vol 2, Iss 3 (2023)
Introduction : L’acide ellagique (AE) est un composé polyphénolique, possédant des propriétés antipaludiques ainsi que d’autres activités thérapeutiques prometteuses. Cependant, ses propriétés physicochimiques défavorables (faible solub
Externí odkaz:
https://doaj.org/article/ef6c6c45c534499088ea3dde825d2e5b
Autor:
Nathan Koch, Olivier Jennotte, Anna Lechanteur, Marine Deville, Corinne Charlier, Jean-Michel Cardot, Patrice Chiap, Brigitte Evrard
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 140 (2024)
Cannabidiol (CBD) has multiple therapeutic benefits that need to be maximized by optimizing its bioavailability. Numerous formulations are therefore being developed and their pharmacokinetics need to be studied, requiring analytical methods and data
Externí odkaz:
https://doaj.org/article/dcb0db63d7df4ec8adad28b217558f96
Autor:
Manon Berger, Manon Degey, Jeanne Leblond Chain, Erik Maquoi, Brigitte Evrard, Anna Lechanteur, Géraldine Piel
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 597 (2023)
Polyethylene glycol (PEG) is used in Lipid Nanoparticles (LNPs) formulations to confer stealth properties and is traditionally anchored in membranes by a lipid moiety whose length significantly impacts the LNPs fate in vivo. C18 acyl chains are effic
Externí odkaz:
https://doaj.org/article/51c8b20c134b49eeb3995cca874148b5
Autor:
Anna Lechanteur, Brigitte Evrard
Publikováno v:
Pharmaceutics, Vol 12, Iss 1, p 55 (2020)
Although dry powder inhalers (DPIs) have attracted great interest compared to nebulizers and metered-dose inhalers (MDIs), drug deposition in the deep lung is still insufficient to enhance therapeutic activity. Indeed, it is estimated that only 10−
Externí odkaz:
https://doaj.org/article/559240e38b9243bab9abc48fd6d3488c
Autor:
Anna Lechanteur, Vincent Sanna, Amandine Duchemin, Brigitte Evrard, Denis Mottet, Géraldine Piel
Publikováno v:
Nanomaterials, Vol 8, Iss 5, p 270 (2018)
In recent year, cationic liposomes have gained a lot of attention for siRNA delivery. Despite this, intracellular barriers as endosomal escape and cytosolic delivery of siRNA still represent a challeng, as well as the cytotoxicity due to cationic lip
Externí odkaz:
https://doaj.org/article/18fe385eba1e45ae9eb7d256c6958095
Autor:
Chloé Parulski, Eva Gresse, Olivier Jennotte, Alexandre Felten, Eric Ziemons, Anna Lechanteur, Brigitte Evrard
Publikováno v:
International journal of pharmaceutics. 626
Many active principles belong to the second class of the Biopharmaceutics Classification System due to their low aqueous solubility. Elaboration of new solid oral forms by hot-melt extrusion and fused deposition modeling appears as a promising tool t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa943dcbc33dbbfd8134fcfaca37769
https://pubmed.ncbi.nlm.nih.gov/36055443
https://pubmed.ncbi.nlm.nih.gov/36055443
Autor:
Isaïe NYAMBA, Olivier JENNOTTE, Charles B SOMBIE, Anna LECHANTEUR, Pierre-Yves SACRE, Abdoulaye DJANDE, Rasmané SEMDE, Brigitte EVRARD
Publikováno v:
International Journal of Pharmaceutics. :123088
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::046f2b5b3c390c9ab62f9829eb6cdc8d
https://doi.org/10.1016/j.ijpharm.2023.123088
https://doi.org/10.1016/j.ijpharm.2023.123088
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 159:198-210
Ellagic acid (EA) is a polyphenolic active compound with antimalarial and other promising therapeutic activities. However, its solubility and its permeability are both low (BCS IV). These properties greatly compromise its oral bioavailability and cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e662763f4e873c47dfcaac88c34451
https://doi.org/10.1016/j.ejpb.2020.11.004
https://doi.org/10.1016/j.ejpb.2020.11.004